Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridos
Mais vistas
- Cuba denuncia e adverte sobre ataques israelenses indiscriminados em Damasco e Beirute, inclusive perto de suas sedes diplomáticas
- Terremoto perceptível no leste cubano
- Ministro das Relações Exteriores: O novo veto dos EUA é prova de cumplicidade com o genocídio israelense
- Salão da Fama da República Dominicana homenageia o lutador cubano Mijaín López
- Marabana cresce em 2024
